Endocardial fibroelastosis

Endocardial Fibroelastosis is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications.

Causes

The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications.

Symptoms

Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include:

• Shortness of breath
• Fatigue
• Rapid heartbeat
• Swelling in the legs, ankles, and feet

Diagnosis

Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an Echocardiogram, Electrocardiogram, and Cardiac MRI.

Treatment

Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a Heart transplant may be necessary.

Prognosis

The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life.

See also

• Cardiomyopathy
• Heart failure
• Pediatric cardiology

Endocardial fibroelastosis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia